Gene · 4300
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RAS and PP2A activities converge on epigenetic gene regulation. | Life Sci Alliance | 2023 | 36858798 | PubTator, text mining | PubMed |
| Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of AGTR1+ CAFs in intrahepatic cholangiocarcinoma. | Clin Transl Med | 2023 | 36855786 | PubTator, text mining | PubMed |
| Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing. | Blood Adv | 2023 | 36848637 | PubTator, text mining | PubMed |
| Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. | Signal Transduct Target Ther | 2023 | 36843114 | PubTator, text mining | PubMed |
| Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario. | Pharmaceutics | 2023 | 36839989 | PubTator, text mining | PubMed |
| In Silico Identification and Functional Characterization of Genetic Variations across DLBCL Cell Lines. | Cells | 2023 | 36831263 | PubTator, text mining | PubMed |
| Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review. | Biomolecules | 2023 | 36830619 | PubTator, text mining | PubMed |
| Research progress on molecular biomarkers of acute myeloid leukemia. | Front Oncol | 2023 | 36824144 | PubTator, text mining | PubMed |
| Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia. | Haematologica | 2023 | 36815378 | PubTator, text mining | PubMed |
| Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma. | Biomed Res Int | 2023 | 36814797 | PubTator, text mining | PubMed |
| Dipeptidylpeptidase 4 promotes survival and stemness of acute myeloid leukemia stem cells. | Cell Rep | 2023 | 36807138 | PubTator, text mining | PubMed |
| Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine. | Mol Cell Proteomics | 2023 | 36805445 | PubTator, text mining | PubMed |
| Into the multi-omics era: Progress of T cells profiling in the context of solid organ transplantation. | Front Immunol | 2023 | 36798139 | PubTator, text mining | PubMed |
| Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group. | Pediatr Blood Cancer | 2023 | 36789545 | PubTator, text mining | PubMed |
| Conformational and Thermodynamic Differences Underlying Wild-Type and Mutant Eleven-Nineteen-Leukemia YEATS Domain Specificity for Epigenetic Marks. | J Chem Inf Model | 2023 | 36786550 | PubTator, text mining | PubMed |
| FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | J Hematol Oncol | 2023 | 36774506 | PubTator, text mining | PubMed |
| CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm. | Int J Mol Sci | 2023 | 36769040 | PubTator, text mining | PubMed |
| Molecular Mechanisms in Murine Syngeneic Leukemia Stem Cells. | Cancers (Basel) | 2023 | 36765677 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling of human HSCs during development: new insights into HSC ontogeny. | Signal Transduct Target Ther | 2023 | 36746910 | PubTator, text mining | PubMed |
| A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia. | Front Immunol | 2023 | 36742324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4300/papers?page=15